Similar articles for PMID: 26849079

Year	Number of Results
1983	1
1985	1
1992	1
1994	2
1995	1
1996	3
1997	3
1998	2
1999	2
2000	5
2001	3
2002	3
2003	3
2005	5
2006	4
2007	3
2008	9
2009	5
2010	1
2011	3
2012	4
2013	3
2014	4
2015	3
2016	6
2017	6
2018	5
2019	3
2020	4
2021	4
2022	4
2023	3
2024	0

1

Durable Response to Treatment With Combination Radiotherapy and High-dose Interleukin-2 in Metastatic Chromophobe Variant Renal Cell Carcinoma.

Merriman J, Tward J, Albertson D, Dechet C, Agarwal N. Merriman J, et al. J Immunother. 2016 Feb-Mar;39(2):101-3. doi: 10.1097/CJI.0000000000000106. J Immunother. 2016. PMID: 26849079

2

Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series.

Volpe A, Novara G, Antonelli A, Bertini R, Billia M, Carmignani G, Cunico SC, Longo N, Martignoni G, Minervini A, Mirone V, Simonato A, Terrone C, Zattoni F, Ficarra V; Surveillance and Treatment Update on Renal Neoplasms (SATURN) Project; Leading Urological No-Profit Foundation for Advanced Research (LUNA) Foundation. Volpe A, et al. BJU Int. 2012 Jul;110(1):76-83. doi: 10.1111/j.1464-410X.2011.10690.x. Epub 2011 Nov 1. BJU Int. 2012. PMID: 22044519

3

Radiotherapy as an immunological booster in patients with metastatic melanoma or renal cell carcinoma treated with high-dose Interleukin-2: evaluation of biomarkers of immunologic and therapeutic response.

Ridolfi L, de Rosa F, Ridolfi R, Gentili G, Valmorri L, Scarpi E, Parisi E, Romeo A, Guidoboni M. Ridolfi L, et al. J Transl Med. 2014 Sep 23;12:262. doi: 10.1186/s12967-014-0262-6. J Transl Med. 2014. PMID: 25245327 Free PMC article. Clinical Trial.

4

[Clinical study on recombinant human interleukin-2 (Proleukin) in the treatment of metastatic renal cell carcinoma].

Sheng XN, Li JL, Guo J, Zhao XH, Zhu J, Chu DT. Sheng XN, et al. Zhonghua Zhong Liu Za Zhi. 2008 Feb;30(2):129-33. Zhonghua Zhong Liu Za Zhi. 2008. PMID: 18646697 Clinical Trial. Chinese.

5

Lack of efficacy of two consecutive treatments of radioimmunotherapy with 131I-cG250 in patients with metastasized clear cell renal cell carcinoma.

Brouwers AH, Mulders PF, de Mulder PH, van den Broek WJ, Buijs WC, Mala C, Joosten FB, Oosterwijk E, Boerman OC, Corstens FH, Oyen WJ. Brouwers AH, et al. J Clin Oncol. 2005 Sep 20;23(27):6540-8. doi: 10.1200/JCO.2005.07.732. J Clin Oncol. 2005. PMID: 16170161 Clinical Trial.

6

Clinical outcome of combined immunotherapy with interferon-alpha and low-dose interleukine-2 for Japanese patients with metastatic renal cell carcinoma.

Miyake H, Kurahashi T, Takenaka A, Inoue TA, Fujisawa M. Miyake H, et al. Urol Oncol. 2009 Nov-Dec;27(6):598-603. doi: 10.1016/j.urolonc.2008.07.023. Epub 2008 Sep 25. Urol Oncol. 2009. PMID: 18818106

7

Complete response in a cutaneous facial metastatic nodule from renal cell carcinoma after hypofractionated radiotherapy.

Gay HA, Cavalieri R, Allison RR, Finley J, Quan WD Jr. Gay HA, et al. Dermatol Online J. 2007 Oct 13;13(4):6. Dermatol Online J. 2007. PMID: 18319003 Free article.

8

Ten-year survival results in metastatic renal cell cancer patients treated with monoimmunotherapy with subcutaneous low-dose interleukin-2.

Lissoni P, Bordin V, Vaghi M, Fumagalli L, Bordoni A, Mengo S, Bucovec R, Fumagalli E, Malugani F, Ardizzoia A, Giani L, Gardani GS, Tancini G. Lissoni P, et al. Anticancer Res. 2002 Mar-Apr;22(2B):1061-4. Anticancer Res. 2002. PMID: 12168901 Clinical Trial.

9

Feasibility and effects of high-dose hypofractionated radiation therapy and simultaneous multi-kinase inhibition with sunitinib in progressive metastatic renal cell cancer.

Staehler M, Haseke N, Stadler T, Nuhn P, Roosen A, Stief CG, Wilkowski R. Staehler M, et al. Urol Oncol. 2012 May-Jun;30(3):290-3. doi: 10.1016/j.urolonc.2010.02.006. Epub 2010 Sep 1. Urol Oncol. 2012. PMID: 20813555

10

Long-term follow-up of patients with metastatic renal cell carcinoma treated with intravenous recombinant interleukin-2 in Europe.

Negrier S, Maral J, Drevon M, Vinke J, Escudier B, Philip T. Negrier S, et al. Cancer J Sci Am. 2000 Feb;6 Suppl 1:S93-8. Cancer J Sci Am. 2000. PMID: 10685667 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

101 results

Results by year